Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given New $14.00 Price Target at HC Wainwright

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) had its target price reduced by investment analysts at HC Wainwright from $18.50 to $14.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 142.63% from the company’s previous close.

SENS has been the topic of several other reports. Stifel Nicolaus dropped their price target on Senseonics Holdings, Inc. Common Stock from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Monday. Weiss Ratings assumed coverage on Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, February 17th. They set a “sell (d-)” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Senseonics Holdings, Inc. Common Stock presently has an average rating of “Moderate Buy” and a consensus target price of $17.00.

Senseonics Holdings, Inc. Common Stock Stock Up 14.7%

Shares of SENS opened at $5.77 on Tuesday. The firm has a 50 day simple moving average of $6.52. Senseonics Holdings, Inc. Common Stock has a 52-week low of $4.79 and a 52-week high of $13.40. The firm has a market cap of $241.19 million, a price-to-earnings ratio of -2.89 and a beta of 1.05. The company has a debt-to-equity ratio of 0.58, a quick ratio of 4.55 and a current ratio of 4.83.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.65) by ($0.06). The firm had revenue of $11.71 million for the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 213.87% and a negative return on equity of 111.78%. On average, equities analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.83 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Timothy T. Goodnow acquired 17,225 shares of the stock in a transaction that occurred on Friday, March 13th. The stock was purchased at an average cost of $5.79 per share, for a total transaction of $99,732.75. Following the purchase, the chief executive officer directly owned 651,243 shares in the company, valued at $3,770,696.97. This represents a 2.72% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Douglas A. Roeder acquired 17,500 shares of the stock in a transaction that occurred on Friday, March 13th. The shares were bought at an average price of $5.73 per share, with a total value of $100,275.00. Following the completion of the purchase, the director owned 119,731 shares in the company, valued at $686,058.63. The trade was a 17.12% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 4.70% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Kestra Advisory Services LLC bought a new position in Senseonics Holdings, Inc. Common Stock during the 1st quarter worth $68,000. GSK plc bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter worth $60,000. Townsend Asset Management Corp NC ADV bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter worth $60,000. Sanctuary Advisors LLC bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter worth $71,000. Finally, Captrust Financial Advisors bought a new position in shares of Senseonics Holdings, Inc. Common Stock in the fourth quarter worth $77,000. 12.36% of the stock is currently owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.